Key facts
- Notable investors include The Engine, MaC Venture Capital, Adverb Ventures, Epsilon Ventures.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Bioqore
- ·The full record, as it builds
Funding rounds
No funding rounds for Bioqore are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Bioqore
Developer of an AI-driven biomanufacturing platform designed to optimize bioprocess development and scale biologic production. The company offers proprietary AI models trained on real lab data, integrated with in-house experimental research, enabling biopharma researchers to reduce trial-and-error and accelerate the path from discovery to production.
- Sector
- Healthcare
- HQ
- Natick, MA, United States
- Founded
- 2024
- Employees
- 8
- Website
- bioqore.ai/
- Ownership
- Privately Held (backing)
Bioqore doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Bioqore shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Bioqore in its N-PORT filings yet. We sweep new filings monthly.